tiprankstipranks
Embla Medical hf (OSSFF)
OTHER OTC:OSSFF
US Market
OSSFF
Embla Medical hf
RESEARCH TOOLSreports

Embla Medical hf (OSSFF) Ratios

13 Followers

Embla Medical hf Ratios

OSSFF's free cash flow for Q2 2026 was $0.63. For the 2026 fiscal year, OSSFF's free cash flow was decreased by $ and operating cash flow was $0.17. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
 1.25 1.48 1.92 1.47 1.71
Quick Ratio
 0.82 0.94 1.22 0.91 1.15
Cash Ratio
 0.26 0.33 0.37 0.32 0.46
Solvency Ratio
 0.20 0.18 0.16 0.09 0.14
Operating Cash Flow Ratio
 0.39 0.46 0.48 0.26 0.54
Short-Term Operating Cash Flow Coverage
 0.95 2.10 2.18 0.70 1.49
Net Current Asset Value
$ -324.49M$ -391.71M$ -304.70M$ -341.00M$ -302.09M
Leverage Ratios
Debt-to-Assets Ratio
 0.31 0.31 0.34 0.36 0.36
Debt-to-Equity Ratio
 0.58 0.61 0.67 0.76 0.72
Debt-to-Capital Ratio
 0.37 0.38 0.40 0.43 0.42
Long-Term Debt-to-Capital Ratio
 0.18 0.25 0.38 0.38 0.38
Financial Leverage Ratio
 1.87 1.96 1.97 2.08 2.01
Debt Service Coverage Ratio
 1.00 1.84 2.07 0.78 1.28
Interest Coverage Ratio
 6.33 5.91 4.98 5.99 9.76
Debt to Market Cap
 0.20 0.17 0.27 0.24 0.16
Interest Debt Per Share
 1.29 1.32 1.16 1.18 1.08
Net Debt to EBITDA
 2.14 2.31 2.75 4.52 3.03
Profitability Margins
Gross Profit Margin
60.28%58.18%60.77%61.19%63.37%
EBIT Margin
14.30%13.18%11.76%9.38%13.31%
EBITDA Margin
20.72%19.71%18.01%12.45%16.68%
Operating Profit Margin
13.66%13.43%11.19%9.34%13.31%
Pretax Profit Margin
12.38%11.62%9.51%7.82%12.06%
Net Profit Margin
9.54%8.97%7.31%5.92%8.90%
Continuous Operations Profit Margin
9.58%9.01%7.36%6.01%9.14%
Net Income Per EBT
77.08%77.21%76.82%75.68%73.86%
EBT Per EBIT
90.65%86.56%85.03%83.67%90.60%
Return on Assets (ROA)
5.45%4.96%4.21%3.21%5.13%
Return on Equity (ROE)
10.47%9.73%8.32%6.69%10.30%
Return on Capital Employed (ROCE)
9.97%9.02%7.51%6.17%9.02%
Return on Invested Capital (ROIC)
6.79%6.56%5.61%4.39%6.43%
Return on Tangible Assets
11.84%10.78%9.28%7.29%11.77%
Earnings Yield
5.25%3.97%3.43%2.11%2.34%
Efficiency Ratios
Receivables Turnover
 6.46 6.29 5.29 5.48 5.95
Payables Turnover
 9.94 12.30 9.76 9.73 9.85
Inventory Turnover
 2.41 2.44 2.20 2.11 2.53
Fixed Asset Turnover
 4.19 3.98 4.29 4.01 3.95
Asset Turnover
 0.57 0.55 0.58 0.54 0.58
Working Capital Turnover Ratio
 11.43 5.74 5.48 5.90 4.62
Cash Conversion Cycle
 171.36 178.04 197.27 202.07 168.42
Days of Sales Outstanding
 56.49 58.03 68.99 66.65 61.30
Days of Inventory Outstanding
 151.59 149.68 165.68 172.92 144.16
Days of Payables Outstanding
 36.72 29.67 37.40 37.50 37.04
Operating Cycle
 208.08 207.71 234.67 239.57 205.46
Cash Flow Ratios
Operating Cash Flow Per Share
 0.34 0.33 0.22 0.15 0.24
Free Cash Flow Per Share
 0.29 0.28 0.12 0.08 0.17
CapEx Per Share
 0.05 0.05 0.10 0.06 0.06
Free Cash Flow to Operating Cash Flow
 0.85 0.84 0.55 0.57 0.73
Dividend Paid and CapEx Coverage Ratio
 6.66 6.19 2.23 2.34 3.77
Capital Expenditure Coverage Ratio
 6.66 6.19 2.23 2.34 3.77
Operating Cash Flow Coverage Ratio
 0.28 0.26 0.20 0.13 0.22
Operating Cash Flow to Sales Ratio
 0.15 0.15 0.12 0.08 0.14
Free Cash Flow Yield
7.07%5.46%3.05%1.73%2.71%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 18.93 25.50 29.18 47.31 42.65
Price-to-Sales (P/S) Ratio
 1.80 2.26 2.13 2.80 3.80
Price-to-Book (P/B) Ratio
 1.94 2.45 2.43 3.16 4.39
Price-to-Free Cash Flow (P/FCF) Ratio
 14.14 18.31 32.74 57.75 36.96
Price-to-Operating Cash Flow Ratio
 12.13 15.35 18.07 33.10 27.15
Price-to-Earnings Growth (PEG) Ratio
 0.64 1.02 0.73 -1.42 0.05
Price-to-Fair Value
 1.94 2.45 2.43 3.16 4.39
Enterprise Value Multiple
 10.83 13.78 14.59 27.00 25.80
Enterprise Value
 2.20B 2.62B 2.10B 2.42B 3.09B
EV to EBITDA
 10.83 13.78 14.59 27.00 25.80
EV to Sales
 2.24 2.72 2.63 3.36 4.30
EV to Free Cash Flow
 17.62 22.00 40.33 69.35 41.88
EV to Operating Cash Flow
 14.97 18.45 22.25 39.75 30.76
Tangible Book Value Per Share
 >-0.01 -0.11 -0.12 -0.26 -0.18
Shareholders’ Equity Per Share
 2.14 2.08 1.67 1.52 1.47
Tax and Other Ratios
Effective Tax Rate
 0.23 0.23 0.23 0.23 0.24
Revenue Per Share
 2.28 2.26 1.90 1.72 1.70
Net Income Per Share
 0.22 0.20 0.14 0.10 0.15
Tax Burden
 0.77 0.77 0.77 0.76 0.74
Interest Burden
 0.87 0.88 0.81 0.83 0.91
Research & Development to Revenue
 0.05 0.04 0.05 0.05 0.04
SG&A to Revenue
 0.42 0.42 0.08 0.10 0.10
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 <0.01 <0.01
Income Quality
 1.27 1.64 1.06 0.94 1.03
Currency in USD